Prescriptions of dangerous ‘chemical cosh’ drugs to dementia-stricken care home residents soared by 50 per cent during Covid, research showed today.
University of Exeter and King’s College London researchers discovered the use of antipsychotic drugs among homes soared from 18 per cent in 2017 to 28 per cent this year.
The tranquilisers are usually prescribed to schizophrenia patients to help prevent hallucinations.